Equity Research
William Blair macro analyst Richard de Chazal was quoted in a Reuters story focused on several key macro and market-specific developments that were impacting markets this June.
“The scattered conflict with Iran continues, seemingly following the established pattern of heightened tensions into the weekend before those are resolved ahead of Monday’s market open,” de Chazal wrote in a note to investors that was cited by the publication.
Stay up-to-date with the latest William Blair news and insights
William Blair initiated research coverage of Zentalis Pharmaceuticals, Inc. (ZNTL $3.50), a clinical-stage biotech company focused on developing azenosertib, a small-molecule WEE1 inhibitor, for the treatment of ovarian cancer and other tumors.
William Blair initiated research coverage of The Metals Royalty Company Inc. (TMCR $5.41). The Metals Royalty Company is focused on acquiring critical metals and energy royalty interests that support U.S. mineral security, with key royalties in the NORI and Mesabi projects.
Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.
For disclosure information, please visit www.williamblair.com/disclosures
